Allergic rhinitis
Conditions
Interventions
Treatment group:None
Control group:None
Sponsors
Chongqing General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >=18 years; 2. Diagnosed with seasonal allergic rhinitis (SAR); 3. Allergen-specific IgE positive (>=3.5 UA/mL); 4. Symptoms are not adequately controlled by conventional therapy (such as antihistamines and nasal steroids); 5. The patient fully understands this study, voluntarily participates, and signs the informed consent form (ICF).
Exclusion criteria
Exclusion criteria: 1. Having other types of rhinitis (such as chronic sinusitis); 2. Having undergone nasal surgery or other immunomodulatory treatment within the past year; 3. Allergy to omalizumab, excipients of the treatment drug, or other biologics, or having a history of severe drug allergy or anaphylactic shock; 4. Having serious cardiovascular, liver, kidney, or other systemic diseases that may affect study results or increase treatment risks; 5. Pregnant or breastfeeding women; 6. Having a history of severe neurological or psychiatric disorders; 7. Patients whom the investigator deems unsuitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Daily Nasal Symptom Score,DNSS;Quality of Life Score;Daily Medication Score; | — |
Countries
China
Contacts
Public ContactDan Zeng
Chongqing General Hospital
Outcome results
None listed